维普期刊资源整合服务平台（V6.5）

338篇 您的检索式：作者名="Jukema"

选中清除导出查看参考文献查看引证文献引用追踪共17页首页上一页第1页下一页末页 /17 跳转

	题名	作者	年代	出处	被引量
1	高危心血管病老年人血压变异性的相关因素显示文摘诊问血压变异性是心血管病的独立预测因素。该研究探讨老年人血压变异的相关因素。方法:在普伐他汀干预高危老年人的前瞻性研究( pravastatin inelderly individuals at risk of vascular disease, PROS-PER)中,分析70~82岁有心血管病史或危险因素的男性和女性者3794人。	Poortvliet RK Lloyd SM Ford I Sattar N de Craen AJ Wijsman LW Mooijaart SP Westendorp G Jukema JW de Ruijter W Gussekloo J Stott DJ	2015	中华高血压杂志2015，23，10：	3
2	Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials显示文摘	Naveed Sattar David Preiss Heather M Murray Paul Welsh Brendan M Buckley Anton JM de Craen Sreenivasa Rao Kondapally Seshasai John J McMurray Dilys J Freeman J Wouter Jukema Peter W Macfarlane Chris J Packard David J Stott Rudi G Westendorp James Shepherd	2010	The Lancet2010，，9716：	2
3	Head-to-Head Comparison of Coronary Plaque Evaluation Between Multislice Computed Tomography and Intravascular Ultrasound Radiofrequency Data Analysis显示文摘	Gabija Pundziute Joanne D. Schuijf J. Wouter Jukema Isabel Decramer Giovanna Sarno Piet K. Vanhoenacker Johannes H.C. Reiber Martin J. Schalij William Wijns Jeroen J. Bax	2008	JACC: Cardiovascular Interventions2008，，2：	2
4	CETP as a Target in HDL-raising Therapy:lessons from APOE*3-Leiden. CETP Transgenic Mice显示文摘Background Cardiovascular disease (CVD) is mainly caused by atherosclerosis,for which dyslipidemia (i.e. high (V)LDL-cholesterol (C),high triglycerides and low HDLC is a major risk factor. To reduce the risk to develop CVD,patients with dyslipidemia are usually treated with lipid-lowering drugs including statins and fibrates.	Willeke de Haan Jitske de Vries-van der Weij Caroline C. van der Hoogt José W.A. van der Hoorn Johannes A. Romijn J. Wouter Jukema Louis M. Havekes Hans M.G. Princen Patrick C.N. Rensen	2009	中国动脉硬化杂志2009，17，7：	2
5	Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials显示文摘	Naveed Sattar David Preiss Heather M Murray Paul Welsh Brendan M Buckley Anton JM de Craen Sreenivasa Rao Kondapally Seshasai John J McMurray Dilys J Freeman J Wouter Jukema Peter W Macfarlane Chris J Packard David J Stott Rudi G Westendorp James Shepherd	2010	The Lancet2010，，9716：	2
6	Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease显示文摘	Beishuizen ED van de Ree MA Jukema JW el al	2004	Diabetes Care2004，27，12：	1
7	Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease显示文摘	Pundziute G Schuijf J D Jukema J W	2007	Am Coll Cardiol2007，49，11：	1
8	Atorvastatin in- hibits plaque development and adventitial neovasculariza- tion in ApoE deficient mice independent of plasma choles-terol levels 显示文摘	Bot I Jukema JW Lankhuizen IM	2011	Atherosclerosis2011，214，2：	1
9	Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevationmyocardial infarction: 9 -Month angiographic and intravascular ultrasound results and 12-month clinical outcome: results from the MISSION! Intervention Study 显示文摘	van der Hoeven BL Liem SS Jukema JW	2008	J Am Coil Cardiol2008，51，：	1
10	Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty(REGRESS trial)显示文摘	Mulder HJ Bal ET Jukema JW Zwinderman AH Schalij MJ van Boven AJ	2000	Am J Cardiol2000，86，7：	1
11	p27kip1–838C>A Single Nucleotide Polymorphism Is Associated With Restenosis Risk After Coronary Stenting and Modulates p27kip1 Promoter Activity显示文摘	Claudia M. van Tiel Peter I. Bonta Saskia Z.H. Rittersma Marcel A.M. Beijk Edward J. Bradley Anita M. Klous Karel T. Koch Frank Baas J Wouter Jukema Douwe Pons M Lourdes Sampietro Hans Pannekoek Robbert J. de Winter Carlie J.M. de Vries	2009	Circulation2009，，：	1
12	The controversies of statin therapy: Weighing the evidence 显示文摘	Jukema JW Cannon CP de Craen AJ	2012	J Am Coil Cardiol2012，60，10：	1
13	Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels显示文摘	Bot I Jukema JW Lankhuizen IM et al	2011	Atherosclerosis2011，214，2：	1
14	Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease显示文摘	Pundziute G Schuijf JD Jukema JW	2007	J Am Coll Cardiol2007，49，1：	1
15	A comparative regional analysis of coronary atherosclerosis and calcium score on multi- slice CT versus myocardial perfusion on SPECT显示文摘	Schuijf J D Wijns W Jukema J W	2006	J Nucl Med2006，47，11：	1
16	Feasibility of assessment of coro-nary stent patency using 16-slice computed tomography 显示文摘	Schuijf JD Bax JJ Jukema JW ef al	2004	Am J Car-diol2004，94，42：	1
17	ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting显示文摘	Jakub J. Regieli Pieter A. Doevendans Diederick E. Grobbee Aeilko H. Zwinderman Yolanda van der Graaf John J.P. Kastelein J. Wouter Jukema	2011	Atherosclerosis2011，，2：	1
18	The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease显示文摘	Beishuizen ED Tamsma JT Jukema JW	2005	Diabetes Care2005，28，7：	1
19	Evaluation of Plauecharacteristics in acute coronary syndromes : noninvasive assess-ment with multi-slice computed tomography and invasive evalua-tion with intravascular ultrasound radiofrequeney data analysis显示文摘	Pundziute G Schuijf J D Jukema J W	2008	Eur Heart2008，29，19：	1
20	Type 2 diabetes is associated with more advanced coronary atherosclerosis on multislice computed tomography and virtual histology intravascular ultrasound显示文摘	Pundziute G Schuijf JD Jukema JW	2009	J Nucl Cardiol2009，16，：	1

返回顶部每页显示：

共17页首页上一页第1页下一页末页 /17 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示